European Archives - Page 829 of 1344 - European Medical Journal

EMJ Podcast: The Pathway to the Future of Breast Cancer Care

This episode, sponsored by Veracyte, is an overview of the European Breast Cancer Congress symposium ‘The Pathway to the Future of Breast Cancer Care’,

EMJ Podcast: Musings on 2020

In the final episode of 2020, Jonathan takes a moment to consider how much the healthcare landscape has changed in light of COVID-19.

Artificial Intelligence in Healthcare: What’s in it for Radiology?

The healthcare industry is undergoing a major overhaul in terms of technology, and artificial intelligence (AI) in particular has huge potential to enhance all areas of patient care, from research and development of new therapy options through to diagnosis and treatment of individual patients…

Astellas' Bernie Zeiher on the power of inclusive and diverse teams

Bernie Zeiher is the Chief Medical Officer at Astellas Pharma. Bernie spoke to us about making decisions with the patient in mind, the power of inclusive and diverse teams, and the importance of curiosity and continuous learning

The digital culture wars

How can the industry create a culture that integrates digital transformation within organisations and unites people under a common purpose?

Boosting pharma sales rep’s virtual confidence

During the COVID-19 pandemic, pharmaceutical sales reps have been forced to navigate the virtual playing field, and as they operate in this new territory, their confidence is wavering.

Scientific Update from the Global Meeting of Experts in Dermatology (GMED 2020)

During this Global Meeting of Experts in Dermatology (GMED 2020 – winter edition, hosted by Greece colleagues) symposium, 8 experts of dermatology…

A Conversation on Diversity and Inclusion

We hear from three industry thought leaders who share their insights regarding the importance of championing diversity as well as their vision for pharma’s future.

The gender health gap

How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

EMJ Oncology 8 [Supplement 4] 2020 Feature Image

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…